Calidi Biotherapeutics Inc.
(NYSE American: CLDI) |
$1.720 |
$112.33M |
+8.65% |
California BanCorp
(NASDAQ: CALB) |
$22.870 |
$199.06M |
+0.09% |
Camber Energy Inc.
(NYSE American: CEI) |
$0.132 |
$23.33M |
+7.55% |
Cambium Networks
(NASDAQ: CMBM) |
$2.010 |
$56.07M |
-1.47% |
Can-Fite Biopharma Ltd
(NYSE American: CANF) |
$3.410 |
$16.82M |
-1.73% |
Canaan Inc.
(NASDAQ: CAN) |
$1.200 |
$336.17M |
-0.83% |
Canadian Solar Inc.
(NASDAQ: CSIQ) |
$15.345 |
$1.02B |
-11.20% |
Candel Therapeutics Inc.
(NASDAQ: CADL) |
$6.880 |
$207.95M |
+3.93% |
Canna-Global Acquisition Corp.
(NASDAQ: CNGL) |
$10.440 |
$92.91M |
-7.61% |
Canoo Inc.
(NASDAQ: GOEV) |
$2.740 |
$195.80M |
+2.24% |
Canterbury Park Holding Corporation
(NASDAQ: CPHC) |
$20.980 |
$105.98M |
-1.36% |
Capital Bancorp Inc.
(NASDAQ: CBNK) |
$22.545 |
$321.35M |
+0.24% |
Capricor Therapeutics Inc.
(NASDAQ: CAPR) |
$4.640 |
$152.22M |
-0.43% |
Captivision Inc.
(NASDAQ: CAPT) |
$2.430 |
$71.42M |
+1.67% |
Cara Therapeutics Inc.
(NASDAQ: CARA) |
$0.348 |
$18.45M |
+3.85% |
Caravelle International Group
(NASDAQ: CACO) |
$0.531 |
$32.30M |
-0.96% |
Carbon Revolution Public Limited
(NASDAQ: CREV) |
$6.200 |
$11.59M |
0% |
Cardiff Oncology Inc.
(NASDAQ: CRDF) |
$2.600 |
$115.87M |
+3.59% |
Cardio Diagnostics Holdings Inc.
(NASDAQ: CDIO) |
$0.523 |
$11.80M |
+3.34% |
Cardiol Therapeutics Inc.
(NASDAQ: CRDL) |
$2.115 |
$146.97M |
-0.70% |